CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy
- 30 November 2007
- journal article
- research article
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 11 (6) , 337-340
- https://doi.org/10.1016/j.ejpn.2007.02.009
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophyMuscle & Nerve, 2006
- Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophyNeurology, 2005
- CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophyAnnals of Neurology, 2005
- Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in childrenMuscle & Nerve, 2001
- Expression Profiling in the Muscular DystrophiesThe Journal of cell biology, 2000
- Pre-clinical screening of drugs using the mdx mouseNeuromuscular Disorders, 2000
- Recruitment of mast cells to muscle after mild damageJournal of the Neurological Sciences, 1996
- Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activityJournal of the Neurological Sciences, 1995
- Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosisNeuromuscular Disorders, 1994
- A role for mast cells in the progression of Duchenne muscular dystrophy?: Correlations in dystrophin-deficient humans, dogs, and miceJournal of the Neurological Sciences, 1994